Prime Medicine, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-42.1M | $-49.1M | $-50.6M | $-52.6M | $-51.9M | $-52.5M | $-55.3M | $-45.8M |
| Depreciation & Amortization | $1.8M | $1.9M | $1.9M | $1.9M | $1.7M | $1.6M | $1.5M | $1.3M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $4.6M | — | — | $5.7M | — | — | $5.2M |
| Net Cash from Operating Activities | — | $-42.7M | — | — | $-48.9M | — | — | $-67.7M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $214.0K | — | — | $2.4M | — | — | $2.3M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $43.4M | — | — | $-47.7M | — | — | $-37.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $393.0K | — | — | $6.0M | — | — | $157.3M |
| Net Change in Cash | — | $1.1M | — | — | $-90.6M | — | — | $52.6M |
| Free Cash Flow | — | $-42.9M | — | — | $-51.3M | — | — | $-70.0M |
People calculate too much and think too little.